(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today that it has commenced a private offering of $275 million aggregate principal amount ...
Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibilityAdditional proceeds used to pay for the capped call with a premium of at least 75% ...
From delayed diagnoses to missed follow-up care, health care navigation can become overwhelming. Here’s how to stay informed ...
Opinion
4dOpinion
Editor's Note: The algorithm was not built to inform you, and confusing that has cost us
Curation by human beings who know this place and are accountable to it is the only reliable antidote to engineered content.
As the world becomes more digitalized, we find ourselves moving away from traditional pen and paper note-taking and toward secure encrypted note-taking apps. For those who value privacy and security, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results